HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
4th Edition of
International Ophthalmology Conference
March 23-25, 2026 | Singapore
Ocular Oncology and Eye Tumours
Ocular Oncology and Eye Tumours
Ocular tumors, often known as eye tumors, are tumors that affect the eyes. A tumor is a collection of abnormally growing cells that can be either malignant (cancerous) or benign (non-cancerous) (noncancerous). Metastatic eye tumors are the most prevalent type of eye tumor. The study and treatment of cancers in or around the eye is referred to as ocular oncology. These tumors can range from benign to life-threatening, and they can result in vision loss or the loss of the eye itself. Ocular care for people with eye cancer is a unique field. Certainly, the difficulties encountered are not the same as those encountered in a regular ophthalmic practice.
- Biomarkers and Early Detection of Cancers
- Adjuvant Therapies
- Improved Visual Outcomes After Ocular Melanoma Treatment
- Clinical Care
- Types of Ocular Tumors
- Challenges of Ocular Oncology
Committee Members
Shadrokh Nabili
University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Anna Maria Bassi
University of Genoa, Italy
Tim Jackson
King’s College London, United Kingdom IOC 2026 Speakers
Pio Conti
University of Chieti, Italy
Gowhar Ahmad
Florence Hospital Srinagar, India
Agnieszka Rosa
Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Arrane Selvamogan
Leicestershire Partnership NHS Trust, United KingdomSubmit your abstract Today
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : An advanced 3D human-based in vitro model to identify disease-specific molecular markers of glaucoma neurodegeneration
Anna Maria Bassi, University of Genoa, Italy
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom
Title : Evaluating the quality and readability of AI-generated ophthalmic surgery education: A four-model comparison
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom